Literature DB >> 31844004

Ability of Bicarbonate Supplementation To Sensitize Selected Methicillin-Resistant Staphylococcus aureus Strains to β-Lactam Antibiotics in an Ex Vivo Simulated Endocardial Vegetation Model.

Arnold S Bayer1,2, Selvi C Ersoy1, Warren E Rose3, Ana M Bienvenida4, Yan Q Xiong1,2, Henry F Chambers5.   

Abstract

Supplementation of standard growth media (cation-adjusted Mueller-Hinton Broth [CAMHB]) with bicarbonate (NaHCO3) increases β-lactam susceptibility of selected methicillin-resistant Staphylococcus aureus (MRSA) strains ("NaHCO3 responsive"). This "sensitization" phenomenon translated to enhanced β-lactam efficacy in a rabbit model of endocarditis. The present study evaluated NaHCO3-mediated β-lactam MRSA sensitization using an ex vivo pharmacodynamic model, featuring simulated endocardial vegetations (SEVs), to more closely mimic the host microenvironment. Four previously described MRSA strains were used: two each exhibiting in vitro NaHCO3-responsive or NaHCO3-nonresponsive phenotypes. Cefazolin (CFZ) and oxacillin (OXA) were evaluated in CAMHB with or without NaHCO3 Intra-SEV MRSA killing was determined over 72-h exposures. In both "responsive" strains, supplementation with 25 mM or 44 mM NaHCO3 significantly reduced β-lactam MICs to below the OXA susceptibility breakpoint (≤4 mg/liter) and resulted in bactericidal activity (≥3-log killing) in the model for both OXA and CFZ. In contrast, neither in vitro-defined nonresponsive MRSA strain showed significant sensitization in the SEV model to either β-lactam. At both NaHCO3 concentrations, the fractional time above MIC was >50% for both CFZ and OXA in the responsive MRSA strains. Also, in media containing RPMI plus 10% Luria-Bertani broth (proposed as a more host-mimicking microenvironment and containing 25 mM NaHCO3), both CFZ and OXA exhibited enhanced bactericidal activity against NaHCO3-responsive strains in the SEV model. Neither CFZ nor OXA exposures selected for emergence of high-level β-lactam-resistant mutants within SEVs. Thus, in this ex vivo model of endocarditis, in the presence of NaHCO3 supplementation, both CFZ and OXA are highly active against MRSA strains that demonstrate similar enhanced susceptibility in NaHCO3-supplemented media in vitro.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  MRSA; Staphylococcus aureus; beta-lactams; bicarbonate; methicillin resistance

Mesh:

Substances:

Year:  2020        PMID: 31844004      PMCID: PMC7038310          DOI: 10.1128/AAC.02072-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  39 in total

1.  Plasticity of Escherichia coli cell wall metabolism promotes fitness and antibiotic resistance across environmental conditions.

Authors:  Elizabeth A Mueller; Alexander Jf Egan; Eefjan Breukink; Waldemar Vollmer; Petra Anne Levin
Journal:  Elife       Date:  2019-04-09       Impact factor: 8.140

2.  Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.

Authors:  Anthony M Casapao; David M Jacobs; Dana R Bowers; Nicholas D Beyda; Thomas J Dilworth
Journal:  Pharmacotherapy       Date:  2017-11-02       Impact factor: 4.705

3.  Randomized controlled trial of cephalexin versus clindamycin for uncomplicated pediatric skin infections.

Authors:  Aaron E Chen; Karen C Carroll; Marie Diener-West; Tracy Ross; Joyce Ordun; Mitchell A Goldstein; Gaurav Kulkarni; J B Cantey; George K Siberry
Journal:  Pediatrics       Date:  2011-02-21       Impact factor: 7.124

4.  daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations.

Authors:  Warren E Rose; Steven N Leonard; George Sakoulas; Glenn W Kaatz; Marcus J Zervos; Anjly Sheth; Christopher F Carpenter; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2007-11-12       Impact factor: 5.191

5.  beta-Lactamase-mediated inactivation and efficacy of cefazolin and cefmetazole in Staphylococcus aureus abscesses.

Authors:  M T Fields; B L Herndon; D M Bamberger
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

6.  Optimal treatment of MSSA bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins.

Authors:  Monique R Bidell; Nimish Patel; J Nicholas O'Donnell
Journal:  J Antimicrob Chemother       Date:  2018-10-01       Impact factor: 5.790

7.  Staphylococcus aureus PBP4 is essential for beta-lactam resistance in community-acquired methicillin-resistant strains.

Authors:  Guido Memmi; Sergio R Filipe; Mariana G Pinho; Zhibiao Fu; Ambrose Cheung
Journal:  Antimicrob Agents Chemother       Date:  2008-08-25       Impact factor: 5.191

8.  Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial.

Authors:  Joshua S Davis; Archana Sud; Matthew V N O'Sullivan; James O Robinson; Patricia E Ferguson; Hong Foo; Sebastiaan J van Hal; Anna P Ralph; Benjamin P Howden; Paula M Binks; Adrienne Kirby; Steven Y C Tong; Steven Tong; Joshua Davis; Paula Binks; Suman Majumdar; Anna Ralph; Rob Baird; Claire Gordon; Cameron Jeremiah; Grace Leung; Anna Brischetto; Amy Crowe; Farshid Dakh; Kelly Whykes; Maria Kirkwood; Archana Sud; Mahesh Menon; Lucy Somerville; Shrada Subedi; Shirley Owen; Matthew O'Sullivan; Eunice Liu; Fei Zhou; Owen Robinson; Geoffrey Coombs; Patrician Ferguson; Anna Ralph; Eunice Liu; Simon Pollet; Sebastian Van Hal; Hong Foo; Sebastian Van Hal; Rebecca Davis
Journal:  Clin Infect Dis       Date:  2015-09-08       Impact factor: 9.079

9.  Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens.

Authors:  Leo Lin; Poochit Nonejuie; Jason Munguia; Andrew Hollands; Joshua Olson; Quang Dam; Monika Kumaraswamy; Heriberto Rivera; Ross Corriden; Manfred Rohde; Mary E Hensler; Michael D Burkart; Joe Pogliano; George Sakoulas; Victor Nizet
Journal:  EBioMedicine       Date:  2015-06-10       Impact factor: 8.143

10.  Host-dependent Induction of Transient Antibiotic Resistance: A Prelude to Treatment Failure.

Authors:  Jessica Z Kubicek-Sutherland; Douglas M Heithoff; Selvi C Ersoy; William R Shimp; John K House; Jamey D Marth; Jeffrey W Smith; Michael J Mahan
Journal:  EBioMedicine       Date:  2015-08-11       Impact factor: 8.143

View more
  7 in total

Review 1.  Current Paradigms of Combination Therapy in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does it Work, Which Combination, and For Which Patients?

Authors:  Warren Rose; Michael Fantl; Matthew Geriak; Victor Nizet; George Sakoulas
Journal:  Clin Infect Dis       Date:  2021-12-16       Impact factor: 9.079

2.  Impact of Bicarbonate on PBP2a Production, Maturation, and Functionality in Methicillin-Resistant Staphylococcus aureus (MRSA).

Authors:  Selvi C Ersoy; Henry F Chambers; Richard A Proctor; Adriana E Rosato; Nagendra N Mishra; Yan Q Xiong; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2021-03-01       Impact factor: 5.191

3.  Impact of Bicarbonate-β-Lactam Exposures on Methicillin-Resistant Staphylococcus aureus (MRSA) Gene Expression in Bicarbonate-β-Lactam-Responsive vs. Non-Responsive Strains.

Authors:  Selvi C Ersoy; Blake M Hanson; Richard A Proctor; Cesar A Arias; Truc T Tran; Henry F Chambers; Arnold S Bayer
Journal:  Genes (Basel)       Date:  2021-10-20       Impact factor: 4.096

4.  A Combined Phenotypic-Genotypic Predictive Algorithm for In Vitro Detection of Bicarbonate: β-Lactam Sensitization among Methicillin-Resistant Staphylococcus aureus (MRSA).

Authors:  Selvi C Ersoy; Warren E Rose; Robin Patel; Richard A Proctor; Henry F Chambers; Ewan M Harrison; Youngju Pak; Arnold S Bayer
Journal:  Antibiotics (Basel)       Date:  2021-09-09

5.  Impacts of NaHCO3 on β-Lactam Binding to PBP2a Protein Variants Associated with the NaHCO3-Responsive versus NaHCO3-Non-Responsive Phenotypes.

Authors:  Selvi C Ersoy; Liana C Chan; Michael R Yeaman; Henry F Chambers; Richard A Proctor; Kevin C Ludwig; Tanja Schneider; Adhar C Manna; Ambrose Cheung; Arnold S Bayer
Journal:  Antibiotics (Basel)       Date:  2022-03-30

6.  Scope and Predictive Genetic/Phenotypic Signatures of Bicarbonate (NaHCO3) Responsiveness and β-Lactam Sensitization in Methicillin-Resistant Staphylococcus aureus.

Authors:  Selvi C Ersoy; Mariam Otmishi; Vanessa T Milan; Liang Li; Youngju Pak; Jose Mediavilla; Liang Chen; Barry Kreiswirth; Henry F Chambers; Richard A Proctor; Yan Q Xiong; Vance G Fowler; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

7.  Antibiotics and Innate Immunity: A Cooperative Effort Toward the Successful Treatment of Infections.

Authors:  Andrew Berti; Warren Rose; Victor Nizet; George Sakoulas
Journal:  Open Forum Infect Dis       Date:  2020-07-20       Impact factor: 3.835

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.